NOTCH1 and B-cell chronic lymphocytic leukemia: To better elucidate the mechanism of anti-CD20 therapy refractoriness in the presence of mutated NOTCH1, our group investigated CD20 expression and relative lysis induced by anti-CD20 exposure in vitro in a series of 692 CLL in which 12% harbored mutated NOTCH1 [81].